- Home
- QNRX vs AMIX Comparison
QNRX vs AMIX Comparison
Compare QNRX & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNRX
- AMIX
- Stock Information
- Founded
- QNRX 2018
- AMIX 2014
- Country
- QNRX United States
- AMIX United States
- Employees
- QNRX N/A
- AMIX N/A
- Industry
- QNRX Medical/Dental Instruments
- AMIX
- Sector
- QNRX Health Care
- AMIX
- Exchange
- QNRX Nasdaq
- AMIX NYSE
- Market Cap
- QNRX 3.3M
- AMIX 3.5M
- IPO Year
- QNRX N/A
- AMIX N/A
- Fundamental
- Price
- QNRX $9.60
- AMIX $1.25
- Analyst Decision
- QNRX
- AMIX Strong Buy
- Analyst Count
- QNRX 0
- AMIX 1
- Target Price
- QNRX N/A
- AMIX $5.00
- AVG Volume (30 Days)
- QNRX 12.9K
- AMIX 2.5M
- Earning Date
- QNRX 08-07-2025
- AMIX 08-12-2025
- Dividend Yield
- QNRX N/A
- AMIX N/A
- EPS Growth
- QNRX N/A
- AMIX N/A
- EPS
- QNRX N/A
- AMIX N/A
- Revenue
- QNRX N/A
- AMIX N/A
- Revenue This Year
- QNRX N/A
- AMIX N/A
- Revenue Next Year
- QNRX N/A
- AMIX N/A
- P/E Ratio
- QNRX N/A
- AMIX N/A
- Revenue Growth
- QNRX N/A
- AMIX N/A
- 52 Week Low
- QNRX $5.01
- AMIX $1.14
- 52 Week High
- QNRX $54.95
- AMIX $42.40
- Technical
- Relative Strength Index (RSI)
- QNRX 64.78
- AMIX 35.38
- Support Level
- QNRX $8.04
- AMIX $1.14
- Resistance Level
- QNRX $8.58
- AMIX $1.36
- Average True Range (ATR)
- QNRX 0.46
- AMIX 0.10
- MACD
- QNRX 0.04
- AMIX 0.00
- Stochastic Oscillator
- QNRX 98.57
- AMIX 26.83
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
About AMIX AUTONOMIX MEDICAL INC
Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.